In last trading session, Anavex Life Sciences Corporation (NASDAQ:AVXL) saw 1.23 million shares changing hands with its beta currently measuring 0.84. Company’s recent per share price level of $8.56 trading at $0.54 or 6.73% at ring of the bell on the day assigns it a market valuation of $728.14M. That closing price of AVXL’s stock is at a discount of -68.69% from its 52-week high price of $14.44 and is indicating a premium of 62.03% from its 52-week low price of $3.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.36 million shares which gives us an average trading volume of 1.33 million if we extend that period to 3-months.
For Anavex Life Sciences Corporation (AVXL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Anavex Life Sciences Corporation (NASDAQ:AVXL) trade information
Upright in the green during last session for gaining 6.73%, in the last five days AVXL remained trading in the red while hitting it’s week-highest on Thursday, 03/27/25 when the stock touched $8.56 price level, adding 13.18% to its value on the day. Anavex Life Sciences Corporation’s shares saw a change of -20.30% in year-to-date performance and have moved -8.55% in past 5-day. Anavex Life Sciences Corporation (NASDAQ:AVXL) showed a performance of 1.78% in past 30-days. Number of shares sold short was 24.04 million shares which calculate 24.01 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 11 to the stock, which implies a rise of 22.18% to its current value. Analysts have been projecting 11 as a low price target for the stock while placing it at a high target of 11. It follows that stock’s current price would drop -28.5% in reaching the projected high whereas dropping to the targeted low would mean a loss of -28.5% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0.85% during past 5 years.
Anavex Life Sciences Corporation (NASDAQ:AVXL)’s Major holders
Insiders are in possession of 3.04% of company’s total shares while institution are holding 35.16 percent of that, with stock having share float percentage of 36.27%. Investors also watch the number of corporate investors in a company very closely, which is 35.16% institutions for Anavex Life Sciences Corporation that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at AVXL for having 6.39 million shares of worth $26.97 million. And as of 2024-06-30, it was holding 7.5607 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.55 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.5154 of outstanding shares, having a total worth of $19.19 million.
